PHARMACEUTICAL PRICING POLICY AND CONTROL– INDIAN PERSPECTIVE

Pharmaceutical Price Control Policy, Pharmaceutical Innovation, and Health Durability

Background: The increase in R&D and upward trend of R&D/pharmaceutical sales has occurred despite government controlled pharmaceutical price reduction in Japan. This paper identifies the effect of the government’s price control policy on pharmaceutical innovation and evaluates the influence of new chemical entities (NCE) on health

Pharmaceutical Pricing Policy in Greece: Toward a Different Path

BACKGROUND Affordable, accessible, and innovation-promoting pharmaceutical care is essential to the operation of a sustainable health system. External reference pricing (ERP), a common pharmaceutical policy in Europe, suffers today from indigenous weaknesses that may cause market distortions and barriers to care, burdening mostly the weak economies, and hence, raising ethical and political worr...

Evolution of Pharmaceutical Industry: A global Indian & Gujarat perspective

Most of today's major pharmaceutical companies were founded in the late 19th and early 20th centuries. Key discoveries of the 1920s and 1930s, such as insulin and penicillin, became mass-manufactured and distributed. Global pharmaceutical market is highly dynamic and is characterized by greater levels of R&D expenditure and extensive regulation of its products. Global pharmaceutical sales are e...

Pharmaceutical Pricing and Reimbursement: Canada

Flow Control via Pricing: a Feedback Perspective

This paper discusses network ow control from the perspective of multivariable feedback theory. We build on recent research on ow control based on pricing signals , which has cast these problems in terms amenable to mathematical analysis, and more speciically we focus on the control algorithm of 8]. After reviewing our recent result regarding the stability of this method, we move on to issues of...